2020
DOI: 10.1155/2020/2031701
|View full text |Cite
|
Sign up to set email alerts
|

Ocular Findings in the 16p11.2 Microdeletion Syndrome: A Case Report and Literature Review

Abstract: e recurrent 16p11.2 microdeletion is characterized by developmental delays and a wide spectrum of congenital anomalies. It has been well reported that individuals with this ∼593-kb interstitial deletion have an increased susceptibility toward the autism spectrum disorder (ASD). Abnormalities of the eye and ocular adnexa are also commonly associated findings seen in individuals with the 16p11.2 microdeletion syndrome, although these ophthalmic manifestations have not been well characterized. We conducted an ext… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…It has been concluded that PRRT2-related BFIS typically has a benign prognosis, often resolving with or without medication before the age of 2, and does not result in longterm neurological sequelae and neurodevelopmental delay [1,6,7]. While data have shown that both deletions and duplications at the 16p11.2 locus, which encompasses PRRT2, are associated with an increased risk for ASD [3,12], the connection between PRRT2 mutations and an elevated susceptibility to ASD remains controversial, as deleterious PRRT2 mutations were not found to be enriched in individuals with ASD [1,13]. Furthermore, less than 1% of individuals with PRRT2 heterozygous mutations have ID [1,4].…”
Section: Discussionmentioning
confidence: 99%
“…It has been concluded that PRRT2-related BFIS typically has a benign prognosis, often resolving with or without medication before the age of 2, and does not result in longterm neurological sequelae and neurodevelopmental delay [1,6,7]. While data have shown that both deletions and duplications at the 16p11.2 locus, which encompasses PRRT2, are associated with an increased risk for ASD [3,12], the connection between PRRT2 mutations and an elevated susceptibility to ASD remains controversial, as deleterious PRRT2 mutations were not found to be enriched in individuals with ASD [1,13]. Furthermore, less than 1% of individuals with PRRT2 heterozygous mutations have ID [1,4].…”
Section: Discussionmentioning
confidence: 99%
“…The associated phenotypic spectrum includes autism, mild intellectual disability/developmental delay, and/or possibly other primary psychiatric disorders, with nonspecific major or minor dysmorphisms [13]. Recently, ophthalmic manifestations, a highly penetrant form of obesity, recurrent infections, and extensive phenotypic variability, have also been reported in a literature review in association with this microdeletion syndrome [14]. At the age of 24, the patient was diagnosed with Stargardt maculopathy (OMIM#248200, prevalence: 1/8,000-10,000).…”
Section: Discussionmentioning
confidence: 99%
“…Abnormalities of fingers and toes, such as clinodactyly and syndactyly, have also been observed. Further, 16p11.2 microdeletions are associated with dermatological changes, such as café au lait spots and sacral dimples [Bachmann-Gagescu et al, 2010;Steinman et al, 2016;Demopoulo et al, 2018;Shriberg et al, 2019;Stingl et al, 2020]. Genomic aberrations are clustered in regions corresponding to the major processes of craniofacial development (frontonasal, medial nasal, maxillary, and mandibular development).…”
Section: Discussionmentioning
confidence: 99%